View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
PAED Cisplatin 20 / Radiation, Nasopharyngeal Carcinoma, Part B
Protocol-ID: 682 V1.0 (Mini), PAED CISP20/Radiation Nasopharyngeal Ca, BIndication(s)
- Nasopharyngeal Carcinoma; ICD-10 C11.8, C11.9, C11.-
ST Radiotherapy: simultaneous Radiation |
| Stage I-II: Total dose 45Gy divided into single doses a 1.8 Gy per day on 5 days of the week for 5 weeks, followed by a boost a 14.4 Gy. Regions: Nasopharynx and cervical lymph nodes Stage III-IV: Total dose 45Gy divided into single doses a 1.8 Gy per day on 5 days of the week for 5 weeks, followed by a boost a 14.4 Gy. Regions: Nasopharynx and regional lymph nodes, incl. jugular and supraclavicular regions Patients in complete remission after chemotherapy received only 9 Gy as boost. |
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.09.2021